MannKind | L'Utile Ante Imposte



Pre Tax Profit Cambiamento Data
Adma Biologics USD 36.75M 898K 2024-09
Dynavax Technologies USD 7.63M 12.19M 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
Insmed USD -234282000 14.77M 2024-12
MacroGenics USD 56.31M 111.97M 2024-09
MannKind USD 8.44M 834K 2024-12
Merck USD 5.22B 114M 2024-12
Novo Nordisk DKK 34.38B 9.05B 2024-09
Pfizer USD 4.44B 2.36B 2024-12
Sanofi EUR 2.18B 1.33B 2024-12
Xencor USD -52626000 6.33M 2024-12



MannKind L'Utile Ante Imposte - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.